CD79A and cranioectodermal dysplasia: To investigate amelogenin-specific antibodies in children with untreated CeD, blood samples from patients with CeD (n = 75) and healthy controls (n = 24) were analyzed for IgA and IgG reactivities to amelogenin by ELISA [43].